Current Report Filing (8-k)
July 06 2018 - 5:26PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
Pursuant to Section 13 or 15(d) of The Securities
Exchange Act of 1934
Date of report
(Date of earliest event reported):
July 6, 2018
PEERLOGIX,
INC.
(Exact name of registrant as specified in
its charter)
Nevada
|
333-191175
|
46-4824543
|
(State or Other Jurisdiction
|
(Commission File Number)
|
(IRS Employer
|
of Incorporation)
|
|
Identification No.)
|
480 Sixth Ave., #351, New York,
NY 10011
(Address of Principal Executive Officers)
(Zip Code)
Registrant's
telephone number, including area code:
(914) 550-9993
________________________________________
(Former name or former address, if changed
since last report)
Check the appropriate box below if the Form 8-K filing is intended
to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction
A.2. below):
[_] Written communications pursuant to Rule 425 under the Securities
Act (17 CFR 230.425)
[_] Soliciting material pursuant to Rule 14a-12 under the Exchange
Act (17 CFR 240.14a-12)
[_] Pre-commencement communications pursuant to Rule 14d-2(b)
under the Exchange Act (17 CFR 240.14d-2(b))
[_] Pre-commencement communications pursuant to Rule 13e-4(c)
under the Exchange Act (17 CFR 240.13e-4(c))
Indicate by check mark whether the registrant is an emerging
growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities
Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company [_]
If an emerging growth company, indicate by check mark if the
registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards
provided pursuant to Section 13(a) of the Exchange Act. [_]
Item 8.01 Other Events.
On July 6, 2018, the Board of Directors
of Peerlogix, Inc. (“LOGX”), resolved to offer to the holders of warrants (the “Warrants”) of LOGX (the
“Holders”), and approve the execution of, a warrant repricing and exercise agreement (the “Agreement”)
with each of the consenting Holders, in a form substantially similar to the form attached hereto as
Exhibit 99.1
, whereby
the exercise price of the Warrants shall be reduced from $0.10 to $0.06 per share of common stock of LOGX (the “Common Stock”).
Furthermore, the Board of Directors resolved to offer to the Holders, as outlined in the Agreement, an additional Series B Warrant
(the “Series B”) for every four (4) Warrants exercised pursuant to the Agreement. The Series B shall have an exercise
price of $0.25 per share of the Common Stock.
Item 9.01 Financial Statements
and Exhibits.
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf
by the undersigned hereunto duly authorized.
July 6, 2018
|
|
|
|
Peerlogix, Inc.
/s/ William Gorfein
——————————————
By: William Gorfein
Title: Director
|
|
EXHIBIT INDEX
Peerlogix (CE) (USOTC:LOGX)
Historical Stock Chart
From Mar 2024 to Apr 2024
Peerlogix (CE) (USOTC:LOGX)
Historical Stock Chart
From Apr 2023 to Apr 2024